As national drugs regulator’s subject expert committee approves the use of Bharat Biotech’s Covaxin in children between the age-group of 2-18, health experts have welcomed the development saying it will be beneficial for children and help them resume normal lives but added that there is a need to establish its efficacy globally so that the children are not subject to restrictive measures when they travel abroad.
M.K. Padma Kumar is involved in developing strategies and managing operations for the IPE Global Group.
He has over 25 years of experience in the development sector, working in civil society organisations and international development agencies like DANIDA and DFID. As the Head of State Partnerships at the DFID India, he was responsible for developing partnerships, programme design, management and strategic oversight of all programmes implemented in Bihar, Madhya Pradesh and Odisha. He has managed various development programmes. His expertise lies in driving operational, financial and programmatic transformations. Before DFID, he was associated with Danish International Development Agency (DANIDA), Help Age and World Wildlife Fund.
He holds a Master’s degree in Business Management with specialisation in Human Resource Management and Finance. He is extensively trained in Project Cycle Management, Grant Management, Performance Management, Leadership Skills and Change Management.
